For Feline Diabetes, It’s a Whole New Game

**Click Here to RSVP**

**Please RSVP by April 22, 2024**

Speaker: Andrew Evan Schreibman, DVM

Learning Objectives:

• Review the pathophysiology of feline diabetes
• Understand the mode of action of the two major treatment options: insulin & sodium-glucose cotransporter 2 (SGLT2)-inhibitors
• Review the role of the kidneys in glucose physiology
• Understand the mode of action of sodium-glucose cotransporter 2 (SGLT2)-inhibitors, along with the efficacy & safety data

Bio: Dr. Andrew Schreibman earned his DVM from the College of Veterinary Medicine at Mississippi State University, completed a residency program in Anatomic Pathology at the University of Missouri, and served as a Small Animal Medicine and Surgery Intern at the Department of Veterinary Clinical Medicine with the University of Illinois.

Dr. Schreibman brings over 20 years of diverse education and experience in veterinary medicine built from multiple disciplines – clinical practice, research, academia, and industry. Dr. Schreibman has authored and co-authored several publications and scientific presentations. In his current role as Senior Professional Services Veterinarian, he educates and presents information to colleges, corporate accounts, local associations, sales distributor partners, and individual practices. Passionate about continuous learning and evidence-based medicine, Dr. Schreibman is always seeking opportunities to provide the best education to everyone from pre-veterinary students to specialized key opinion leaders. Outside of veterinary medicine, he umpires high school football and baseball and runs marathons with his wife Lisa.

Sponsor: